Applying Microbiome Intervention Strategies at SNIPR Biome: Precision Bacterial Killing & In Situ Production of Therapeutic Molecules
Time: 12:00 pm
day: Day 2 Track B AM
Details:
- Revealing clinical results from phase 1 study on orally dosed, engineered CRISPR-armed phages designed for precision killing of E. coli
- Outlining preclinical insights from using live bacteria for in situ production of therapeutic molecules to treat cardiometabolic disease
